Mirador Therapeutics
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $583M
Investors
- 22
About Mirador Therapeutics
Founded in 2023 and based in California, US, Mirador Therapeutics, Inc. operates as a biotechnology research company focused on developing precision therapies for immune-mediated diseases. The company was co-founded by Mark C. McKenna (CEO). In February 2024, Mirador Therapeutics, Inc. In September 2025, Mirador Therapeutics, Inc., Farallon Capital Management, Fidelity Management and Research Company, Invus Financial Advisors, Logos Capital, Moore Strategic Ventures, OrbiMed Advisors, Point72, TCG Crossover Management, Venrock Healthcare Capital Partners, and Woodline Partners. The company utilizes a proprietary precision development engine called Mirador360, which integrates recent breakthroughs in human genetics and advanced data to harmonize patient molecular profiles, identify genetic associations, discover therapeutic targets, and develop diagnostics for precise clinical applications. Mirador Therapeutics, Inc.
Who invested in Mirador Therapeutics
22 investors across 2 rounds
See all investors in Mirador Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mirador Therapeutics
Who invested in Mirador Therapeutics?
Mirador Therapeutics has 22 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirador Therapeutics raised?
Mirador Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mirador Therapeutics last raise money?
Mirador Therapeutics's most recent round on record is a Series B, in Sep 2025.
What does Mirador Therapeutics do?
Founded in 2023 and based in California, US, Mirador Therapeutics, Inc.
Where is Mirador Therapeutics headquartered?
Mirador Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Mirador Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mirador Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mirador Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.